We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Radiologix, a radiology services company that develops, consolidates and manages
radiology service networks, announced that Michael Murdock has been appointed
senior vice president and CFO.
Safeguard Medical Technologies of Cleveland, Ohio, has joined forces with British
firm Environmental Asset Management (EAM) to distribute worldwide the Disintegrator,
a needle/lancet destruction device.
The board of directors of devicemaker ZEVEX International have announced that
the responsibilities of chairman of the board and CEO will be separated as a
matter of good corporate governance.
DexCom, a developer of sensors to continuously monitor glucose levels in people
with diabetes, has completed a private Series D financing totaling $22.5 million.
Dade Behring has received clearance from the FDA for the use of its Advanced
D-Dimer assay as an aid in the diagnosis of venous thromboembolism -- deep vein
thrombosis or pulmonary embolism.
Gen-Probe has licensed from Corixa the rights to develop molecular diagnostic
tests for approximately 50 potential genetic markers in the areas of prostate,
ovarian, cervical, kidney, lung and colon cancer, the companies announced.
Response Biomedical has announced that the RAMP Reader and three RAMP Cardiac
Marker Tests have received regulatory clearance in China from the State Food
and Drug Administration (SFDA).
CardioMag Imaging (CMI), located in Schenectady,
N.Y., has announced the signing of a multiyear distribution agreement with a
medical equipment company, Shenzhen Zhiheng Advanced Electrical Technology,
located in Shenzhen, China.